Maggie Beer Holdings Ltd (MBH)
Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026
Key indicators
| Last close | AUD 0.055 |
|---|---|
| 52-week range | 0.047 – 0.120 |
| Return, 1 month / 3 months | +1.9% / −24.7% |
| Return, 1 year / 3 years | −20.3% / −38.2% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 59.7% |
| Worst drawdown (1 year) | -53.6% |
| Average daily value traded | 0.01M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Maggie Beer Holdings is an Australian food company that makes and sells a range of premium foods and ingredients. Its products include verjuice, fruit preserves, sauces, pates and other prepared foods, along with related kitchen and gift items. The company sells to grocery shoppers through supermarkets and specialty retailers as well as directly to consumers, and it is based in Australia. Its brand is associated with the cook Maggie Beer, whose name appears on the products.
Maggie Beer Holdings Ltd trades under the code MBH on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Maggie Beer Holdings Ltd (MBH) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.055 on 20 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 1,241 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.3% and over the last three months it fell 24.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 33 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.7% | ||
| From 52-week high | -50.0% | ||
| Momentum | 31 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -24.7% | ||
| 6-month return | -33.7% | ||
| 12-month return, skipping the last month | -21.7% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 59.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -53.6% | ||
| Liquidity | 19 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M AUD | ||
| Zero-volume days | 26.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.5% |
|---|---|
| 1 month | +1.9% |
| 3 months | −24.7% |
| 6 months | −33.7% |
| 1 year | −20.3% |
| 3 years | −38.2% |
| 5 years | −86.3% |
Signals
| 50-day / 200-day average | 0.058 / 0.073 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.002 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Mar 2023 | AUD 0.0050 |
| 17 Nov 2022 | AUD 0.0100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.